Jaundice - NYSORA

Explore NYSORA knowledge base for free:

Jaundice

Learning objectives

  • Outline the signs and symptoms of jaundice
  • Describe the causes of jaundice and their classification
  • Anesthetic management of a jaundiced patient

Definition and mechanisms

  • Jaundice, or icterus, is a yellowish discoloration of the skin and sclera due to high bilirubin levels
  • Jaundice in adults indicates the presence of underlying diseases involving abnormal heme metabolism, liver dysfunction, or biliary tract obstruction
  • Surgery should be avoided in these patients, only emergency procedures

Signs and symptoms

  • Hyperbilirubinemia (serum bilirubin ≥3 mg/dL)
  • Yellowish discoloration of the skin, mucous membranes, and sclera
  • Itchiness (pruritus)
  • Pale fatty stool (steatorrhea)
  • Dark urine (bilirubinuria)
  • Abdominal pain
  • Fatigue
  • Weight loss
  • Vomiting
  • Fever

Complications

  • Hyperbilirubinemia-induced neurological damage → kernicterus (especially in newborns)
  • Coagulopathy
    • Vitamin K-dependent coagulation factors (II, VII, IX, and X) are reduced, resulting in a prolonged prothrombin time
    • Hepatocellular coagulopathy is often refractory to vitamin K administration
    • Disseminated intravascular coagulation (DIC) is associated with secondary biliary tract infection
  • Altered drug handling
    • Drugs excreted via the biliary system have prolonged elimination half-life in cholestasis
    • Atracurium is the drug of choice for muscular relaxation 
  • Acute oliguric renal failure (17%) 
  • Stress ulceration with gastrointestinal hemorrhage (16%)
  • Reduced wound healing

Causes

CategoryDefinitionCauses
Prehepatic/hemolyticPathology occurs prior to liver metabolism, due to increased breakdown of erythrocytes → increased rate of erythrocyte hemolysis → increased unconjugated serum bilirubin → increased deposition of unconjugated bilirubin into mucosal tissueSickle-cell anemia
Spherocytosis
Thalassemia
Pyruvate kinase deficiency
Glucose-6-phosphate dehydrogenase deficiency
Microangiopathic hemolytic anemiaanemia
Hemolytic-uremic syndrome
Severe malaria
Hepatic/hepatocellularPathology is due to damage of parenchymal liver cells → abnormal liver metabolism of bilirubinAcute hepatitis
Chronic hepatitis
Hepatotoxicity
Cirrhosis
Drug-induced hepatitis
Alcoholic liver disease
Gilbert syndrome
Crigler-Najjar syndrome
Leptospirosis
Posthepatic/cholestatic (obstructive jaundice)Pathology occurs after bilirubin conjugation in the liver, due to obstruction of the biliary tract and/or decreased bilirubin excretionCholedocholithiasis (common bile duct gallstones)
Pancreatic cancer of the pancreatic head
Biliary tract strictures
Biliary atresia
Primary biliary cholangitis
Cholestasis of pregnancy
Acute pancreatitis
Chronic pancreatitis
Pancreatic pseudocysts
Mirizzi syndrome
Parasites

Risk factors

  • Male gender
  • White ethnicities
  • Active smoking

Treatment

  • Based on the underlying cause

Management

jaundice, jaundiced patient, preoperative, intraoperative, postoperative, management, rehydration, antibiotics, vitamin K, H2 antagonists, proton pump inhibitors, urinary catheter, anesthesia, blood gas analysis, electrolytes, lactate, glucose, lactic acidosis, hypoglycemia, blood loss, urine output, temperature, hypothermia, coagulopathy, thromboelastography, dopamine

Suggested reading

  • Pollard BJ, Kitchen G. Handbook of Clinical Anaesthesia. 4th ed. Taylor & Francis group; 2018. Chapter 4 Gastrointestinal tract, Jackson MJ.
  • Wang L, Yu W. Obstructive jaundice and perioperative management. Acta Anaesthesiol Taiwan. 2014;52(1):22-29.

We would love to hear from you. If you should detect any errors, email us customerservice@nysora.com